BSX

Boston Scientific Elects Dr. Jessica L. Mega and Susan E. Morano to Board of Directors

Retrieved on: 
Tuesday, June 27, 2023
Business development, Stanford University, Boston Scientific, BSX, Columbia Business School, Harvard T.H. Chan School of Public Health, Danaher Corporation, Harvard Medical School, Yale School of Medicine, Mega, Villanova University, Public health, Brigham, B.A, Hospital, Johnson & Johnson, Alphabet Inc., Health, Brigham and Women's Hospital, NYSE, Harvard School of Dental Medicine, Management

MARLBOROUGH, Mass., June 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Jessica L. Mega and Susan E. Morano to its board of directors, each effective immediately.

Key Points: 
  • MARLBOROUGH, Mass., June 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced today the election of Dr. Jessica L. Mega and Susan E. Morano to its board of directors, each effective immediately.
  • Prior to joining Verily, Dr. Mega served as a cardiologist at Brigham & Women's Hospital from 2008 to 2015.
  • "We are pleased to expand our board of directors with two highly qualified executives from different sectors of the healthcare industry," said Mike Mahoney, chief executive and chairman of the board, Boston Scientific.
  • "Jessica and Susan are accomplished leaders passionate about advancing patient care and experienced in bringing innovative technologies to market, and we look forward to their contributions as board members as Boston Scientific continues to grow and meet our stakeholder commitments."

AM Best Places Credit Ratings Under Review With Developing Implications for Argus Group Holdings Limited and Its Subsidiaries

Retrieved on: 
Friday, June 9, 2023
Banking, Professional Services, Insurance, Finance, Good, AM Best, ALL, BSX, Bermuda Monetary Authority, Credit, AM, BF, News

AM Best has placed under review with developing implications the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a-” (Excellent) of Argus Insurance Company Limited (Argus Insurance) and Bermuda Life Insurance Company Limited (Bermuda Life).

Key Points: 
  • AM Best has placed under review with developing implications the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a-” (Excellent) of Argus Insurance Company Limited (Argus Insurance) and Bermuda Life Insurance Company Limited (Bermuda Life).
  • Both companies are subsidiaries of Argus Group Holdings Limited (Argus Group) [BSX: AGH.BH].
  • Concurrently, AM Best has placed under review with developing implications the Long-Term ICR of “bbb-” (Good) of Argus Group.
  • The ratings will remain under review with developing implications pending regulatory approvals from the Bermuda Monetary Authority and purchase of shares by Argus.

Miami International Holdings Launches New Real-time Clearing Platform on Minneapolis Grain Exchange

Retrieved on: 
Wednesday, June 7, 2023
Emerald, MIH, MGEX, STP, BSX, Risk management, Bermuda Stock Exchange, DCO, DCM, Artificial intelligence, CIO, Minneapolis Grain Exchange, API, Medical device, Management

PRINCETON, N.J., June 7, 2023 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), LedgerX LLC (LedgerX), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, today announced the successful launch of a new real-time clearing solution for MGEX, a Designated Contract Market (DCM) and Derivatives Clearing Organization (DCO).

Key Points: 
  • PRINCETON, N.J., June 7, 2023 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), LedgerX LLC (LedgerX), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, today announced the successful launch of a new real-time clearing solution for MGEX, a Designated Contract Market (DCM) and Derivatives Clearing Organization (DCO).
  • The new MGEX Clearing System employs a microservices driven design to deliver a real-time, end-to-end clearing solution.
  • Added Mark G. Bagan, President and CEO of MGEX, "The new MGEX Clearing System offers our members a powerful tool to more efficiently manage their clearing processes.
  • Additional information about the new MGEX Clearing System is available here .

Butterfield 2023 Annual General Meeting Voting Results

Retrieved on: 
Thursday, May 25, 2023
Professional Services, Business, Finance, NTB, Bank, Meeting, NYSE, BSX, Holding company

The Bank of N.T.

Key Points: 
  • The Bank of N.T.
  • Butterfield & Son Limited (“the Bank”) (BSX: NTB.BH) (NYSE: NTB) announced the results of the Shareholders’ vote at the Bank’s Annual General Meeting held in virtual format yesterday (May 24, 2023).
  • Each of the proposals numbered 1 through 3 on the Meeting Agenda was approved by the requisite vote, including the re-election of Michael Collins, Alastair Barbour, Sonia Baxendale, Mark Lynch, Ingrid Pierce, Jana Schreuder, Michael Schrum, Pamela Thomas‐Graham and John Wright as Directors.

Data at Heart Rhythm 2023 Highlight Key Boston Scientific Therapies

Retrieved on: 
Saturday, May 20, 2023
Tricuspid valve, Heart Rhythm Society, EU, Freedom, Chosen-ciphertext attack, Heart failure, Pulmonary vein stenosis, Boston Scientific, BSX, Atrial fibrillation, Learning curve, FLX, ICD, NCDR, Catheter ablation, Arrhythmia, DOAC, Atrial tachycardia, Kaplan–Meier estimator, Heart Rhythm, Patient, Molina Healthcare, Physician, Electrophysiology, Data, Risk, LAAC, Diagnosis, Growth, AF, IDE, Ventricular fibrillation, Recurrence, Cardiology, NYSE, Disease, Safety, Journal of the American College of Cardiology, ATLAS, Medical imaging, Pharmaceutical industry, Nursing, Birth control, Medical device

MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management therapies, and the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. All data were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society, held in New Orleans from May 19-21.

Key Points: 
  • All data were presented at Heart Rhythm 2023, the annual meeting of the Heart Rhythm Society, held in New Orleans from May 19-21.
  • The registry data included favorable single procedure success rates, along with efficient procedure times in a broad patient population.
  • Data demonstrated a predictable workflow with a median of 58 minutes within an interquartile range of 40 to 87 minutes.
  • "The data shared at this year's Heart Rhythm meeting showcases the breadth and depth of our cardiology therapies, which spans from diagnosis to treatment of cardiac disease, and highlights the continued growth of our portfolio," said Kenneth Stein, M.D., senior vice president and global chief medical officer, Boston Scientific.

Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference

Retrieved on: 
Monday, May 15, 2023
Boston Scientific, Webcast, Conference, NYSE, EDT, BSX

MARLBOROUGH, Mass., May 15, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023.

Key Points: 
  • MARLBOROUGH, Mass., May 15, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023.
  • Mike Mahoney, chairman and chief executive officer, will participate in a 50-minute question-and-answer session with the host analyst at approximately 8:00 a.m. EDT.
  • A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com .
  • The replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of each event.

MIAX Announces Launch of New Website Designed to Support Growth and Expansion

Retrieved on: 
Monday, April 24, 2023
Emerald, Bermuda Stock Exchange, Growth, Minneapolis Grain Exchange, MIH, History, BSX

PRINCETON, N.J., April 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, today announced the launch of its new corporate website, www.miaxglobal.com .

Key Points: 
  • PRINCETON, N.J., April 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, today announced the launch of its new corporate website, www.miaxglobal.com .
  • The new website has been developed with the user experience in mind and includes features designed to help users navigate the site, including an intuitive layout, enhanced search functionality and improved access to rules and technical information about MIAX and its markets.
  • "The launch of our new corporate website showcases our unified brand and provides our members and the larger trading community with centralized and enhanced access to the resources needed to support trading activity across all of our exchanges," said Thomas P. Gallagher, Chairman and CEO of MIH.
  • "The new website, which consolidates access to information on all of our exchanges, is a testament to our growth and expansion over the past decade, providing the industry with a comprehensive overview of MIH's history and operations as well as our vision for the future."

MIAX Announces Launch of New Website Designed to Support Growth and Expansion

Retrieved on: 
Monday, April 24, 2023
Emerald, Bermuda Stock Exchange, Growth, Minneapolis Grain Exchange, MIH, History, BSX

PRINCETON, N.J., April 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, today announced the launch of its new corporate website, www.miaxglobal.com .

Key Points: 
  • PRINCETON, N.J., April 24, 2023 /PRNewswire/ -- Miami International Holdings, Inc. (MIH), owner of Miami International Securities Exchange, LLC (MIAX®), MIAX PEARL, LLC (MIAX Pearl®), MIAX Emerald, LLC (MIAX Emerald®), Minneapolis Grain Exchange, LLC (MGEX™), The Bermuda Stock Exchange (BSX), and Dorman Trading LLC, today announced the launch of its new corporate website, www.miaxglobal.com .
  • The new website has been developed with the user experience in mind and includes features designed to help users navigate the site, including an intuitive layout, enhanced search functionality and improved access to rules and technical information about MIAX and its markets.
  • "The launch of our new corporate website showcases our unified brand and provides our members and the larger trading community with centralized and enhanced access to the resources needed to support trading activity across all of our exchanges," said Thomas P. Gallagher, Chairman and CEO of MIH.
  • "The new website, which consolidates access to information on all of our exchanges, is a testament to our growth and expansion over the past decade, providing the industry with a comprehensive overview of MIH's history and operations as well as our vision for the future."

Boston Scientific Announces Conference Call Discussing First Quarter 2023 Results

Retrieved on: 
Monday, April 3, 2023
Webcast, News, NYSE, EDT, Boston Scientific, BSX, Cryptocurrency, Broadcasting, Management

MARLBOROUGH, Mass., April 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2023 on Wednesday, April 26, 2023 at 8:00 a.m. EDT.

Key Points: 
  • MARLBOROUGH, Mass., April 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2023 on Wednesday, April 26, 2023 at 8:00 a.m. EDT.
  • The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Dan Brennan, executive vice president and chief financial officer.
  • The company will issue a news release announcing financial results for the first quarter on April 26 prior to the conference call.
  • The replay will be available approximately one hour following the completion of the event.

Scivita Medical enters into Strategic Agreement with Boston Scientific in China

Retrieved on: 
Wednesday, March 29, 2023
Medicine, Partnership, Marketing, Boston Scientific, BSX, COVID-19, Fujifilm, Endoscopy, Hospital, Urology, Patient, Risk, Gynaecology, NYSE, Pharmaceutical industry, Medical device, EU

SUZHOU, China, March 29, 2023 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ('Scivita Medical') and Boston Scientific (NYSE: BSX), one of the leading medical technology companies worldwide, have officially signed a Strategic Agreement for Scivita's Single-Use Percutaneous Choledochoscope.

Key Points: 
  • SUZHOU, China, March 29, 2023 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ('Scivita Medical') and Boston Scientific (NYSE: BSX), one of the leading medical technology companies worldwide, have officially signed a Strategic Agreement for Scivita's Single-Use Percutaneous Choledochoscope.
  • Through this business cooperation and distribution agreement, Scivita Medical and Boston Scientific plan to establish a long-term partnership in the commercialization, marketing and promotion of Scivita's Single-Use Percutaneous Choledochoscope in China.
  • Through the strong alliance with Boston Scientific, the penetration rate of the Single-Use Percutaneous Choledochoscope in China is expected to increase benefiting more hospitals and patients.
  • Scivita Medical said, 'Thanks to Boston Scientific for its recognition of Scivita Medical.